Mr Charlie Davies

Charlie Davies

Updates

Healthcare & Life Sciences

SPCs post-Brexit: where are we now?
United Kingdom | 28 April 2021

Changes to the processes for obtaining marketing authorisations for medicinal products are one of the many differences brought about as a result of the United Kingdom's departure from the European Union. However, behind the high-profile headlines is the knock-on effect that these changes will have on the regime which governs supplementary protection certificates (SPCs) in the United Kingdom. This article considers the changes to the SPC regime and the SPC manufacturing waiver in the United Kingdom.

Intellectual Property

SPCs post-Brexit: where are we now?
United Kingdom | 26 April 2021

Changes to the processes for obtaining marketing authorisations for medicinal products are one of the many differences brought about as a result of the United Kingdom's departure from the European Union. However, behind the high-profile headlines is the knock-on effect that these changes will have on the regime which governs supplementary protection certificates (SPCs) in the United Kingdom. This article considers the changes to the SPC regime and the SPC manufacturing waiver in the United Kingdom.